Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Birgit Braun, Lukas Frank and Thomas Loew
Background: A great need for further scientific assessment of non-pharmacological anxiety management practices and for a quantification of the extent of any benefit provided has been proclaimed. Methods: We have analysed the effectiveness of device-guided breathing by using the Taxxos-Atemtakter™ to reduce the patient`s levels of anxiety. 56 anxious patients were randomly assigned to a control group (C) or a guided breathing group (GB) before undergoing treatment. Anxiety levels were assessed by using validated questionnaires (Hierarchical Anxiety Questionnaire; State-Trait Anxiety Inventory) before and after seeing the dentist. Results: Both groups showed a significant reduction of anxiety levels. However, patients within the GB-group experienced a significantly higher anxiety drop, compared to the C-group (p=0.02). Patients within the GB-group revealed higher pre-post differences regarding state anxiety than in the C group. This reduction was statistically significant (p=0.04) in the group of moderately anxious patients. Conclusions: Device-guided breathing is an effective technique to lower dental anxiety during treatment particularly for moderately anxious patients. Its practice is safe, easy and economically reasonable. Practical implications: Taxxos-Atemtakter™ can be integrated easily and time saving in the treatment process. It can be recommended for the daily use with anxious patients in dental practices.